Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

100.15 +0.19 (+0.19%)

Delayed Quote Updated: 2:17 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings, Inc. - Common Stock

< Previous 1 2

...

18 19 20 21 22 23 24 25 Next >

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 23, 2023

Via Benzinga

Lantheus Reports Fourth Quarter and Full Year 2022 Financial Results

February 23, 2023

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus Presents Data Reinforcing Real-World Clinical Utility of Piflufolastat F 18 PET Scanning in Men with Recurrent Prostate Cancer and Low PSA Levels

February 16, 2023

Data presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium Demonstrate Potential Benefits of Piflufolastat F 18 Decision Making on Treatment Plans

From Lantheus Holdings, Inc.

Via GlobeNewswire

Looking Into Lantheus Holdings's Return On Capital Employed ↗

November 22, 2022

Via Benzinga

Earnings Scheduled For February 23, 2023 ↗

February 23, 2023

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.

Via Benzinga

Meet A Cannabis Executive Who Knows How To Reinvent The Business: Gary Santo Of TILT Holdings ↗

February 13, 2023

After the overwhelming success of last year's Benzinga Cannabis Capital Conference, the team is returning to Florida April 11-12, 2023 with awesome events simultan

Via Benzinga

Lantheus to Host Fourth Quarter and Full Year 2022 Earnings Conference Call and Webcast on February 23, 2023, at 8:00 a.m. Eastern Time

February 09, 2023

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus to Present Piflufolastat F 18 Data at the 2023 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium

February 08, 2023

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus Announces Acquisition of Cerveau Technologies, Inc., Expanding Imaging Pipeline into Alzheimer’s Disease

February 06, 2023

MK-6240 is an F 18-labeled PET imaging agent that targets Tau tangles in Alzheimer’s Disease

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus to Present at the J.P. Morgan 2023 Healthcare Conference

January 04, 2023

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus Announces Closing of Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003 with POINT Biopharma

December 20, 2022

From Lantheus Holdings, Inc.

Via GlobeNewswire

Cramer's Take On This Stock Up 48% Year-To-Date: 'I Would Not Want To Come In At This Level' ↗

December 15, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Royal Caribbean Cruises Ltd (NYSE: RCL) is an "excellent" company.

Via Benzinga

Lantheus Grants Rights for the Use of its Microbubbles to SonoThera for its Ultrasound-Guided Nonviral Gene Therapy Platform

December 12, 2022

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus Holdings, Inc. Announces Pricing of Offering of $500 Million Convertible Senior Notes due 2027

December 06, 2022

From Lantheus Holdings, Inc.

Via GlobeNewswire

Why Iovance Biotherapeutics Shares Are Trading Higher By Around 19%? Here Are 40 Stocks Moving In Monday's Mid-Day Session ↗

December 05, 2022

Gainers Winc, Inc. (NYSE: WBEV) rose 88.5% to $0.3901 after dropping over 23% on Friday. Winc, last month, posted a Q3 loss of $0.33 per share.

Via Benzinga

VF Corp, Verve Therapeutics And Some Other Big Stocks Moving Lower On Monday ↗

December 05, 2022

U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 05, 2022

Via Benzinga

Lantheus Holdings, Inc. Announces Proposed Offering of $500 Million Convertible Senior Notes due 2027

December 05, 2022

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus Holdings Stock Showing Market Leadership; Earns 94 RS Rating ↗

November 29, 2022

Lantheus Holdings stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 90 to 94.

Via Investor's Business Daily

Lantheus Announces Appointment of Amanda Morgan as Senior Vice President, Commercial

November 29, 2022

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus Announces the Approval of DEFINITY® (Perflutren Lipid Microsphere) by China’s NMPA

November 28, 2022

DEFINITY is the leading diagnostic ultrasound enhancing agent for patients with suboptimal echocardiograms

From Lantheus Holdings, Inc.

Via GlobeNewswire

7 Index Funds to Buy to Retire a Millionaire ↗

November 23, 2022

Although the market shows signs of improvement, the waters are still choppy enough for investors to focus on index funds to buy.

Via InvestorPlace

3 Stocks That Could Be the Next Big M&A Targets ↗

November 18, 2022

These three potential M&A deals run the gamut from very possible to very unlikely, despite the benefits of a transaction getting done.

Via InvestorPlace

These 3 Stocks Are Crushing the Market. Wall Street Thinks They Can Soar at Least 78% Higher. ↗

November 18, 2022

The good times could keep on rolling for these big winners.

Via The Motley Fool

PDS Biotechnology To Rally Around 129%? Here Are 5 Other Price Target Changes For Tuesday ↗

November 15, 2022

Via Benzinga

Lantheus-POINT Biopharma Ink Strategic Collaboration For Cancer Programs ↗

November 14, 2022

Via Benzinga

Lantheus and POINT Biopharma Announce Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003

November 14, 2022

From Lantheus Holdings, Inc.

Via GlobeNewswire

S&P 500 Component DexCom Set For Further Price, Earnings Growth

November 13, 2022

Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023.

Via MarketBeat

Topics Stocks

Lantheus to Present at the Jefferies London Healthcare Conference

November 09, 2022

From Lantheus Holdings, Inc.

Via GlobeNewswire

Jim Cramer Says Tesla Has 'The Worst Chart I've Ever Seen': Is He Still A Believer? ↗

November 08, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Antero Resources Corporation (NYSE: AR) is very, very cheap…and "I’m not going to say anything bad about it."

Via Benzinga

< Previous 1 2

...

18 19 20 21 22 23 24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.